Pharmaceuticals, Biotechnology and Life Sciences
GW Pharmaceuticals, a biopharmaceutical company focused on making and selling therapeutics from its cannabinoid product platform, said Monday that the…
Shire said on Monday that it will have 12 presentations at the 14th annual WORLDSymposium 2018 in San Diego, in…
Nymox Pharmaceutical will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US,…
As a media partner for this year’s Pharmapack event in Paris, Pharmaceutical Daily has interviewed Elena Piazza, Business Development and…
At Pharmapack in Paris, Spang & Brands is going to spotlight two innovative pharmaceutical devices: A single-use nasal dosing device…
Allergan’s supplemental New Drug Application (sNDA) to expand the approved use of AVYCAZ has gotten the FDA’s approval.
AstraZeneca’s revenues improved over the course of the year, Pascal Soriot, Chief Executive Officer, commenting on the results said on…
Pacific Biosciences of California said in its fourth quarter results announcement that it has had 19% of increase in product, service…
Gilead Sciences has appointed new member to its board of directors, Jacqueline K. Barton who has previously served on Gilead’s Scientific…
Cardinal Health has disposed a business unit for $1.2 billion – its Cardinal Health China – to Shanghai Pharmaceuticals Holding.